SALL4 activates Wnt/β‐catenin and TGF‐β/SMAD signaling pathways, uncovering a mechanism underlying EMT in esophageal squamous cell carcinoma and gastric cancer [17, 18]. This evidence concerns the gene SALL4 and esophageal squamous cell carcinoma.